A flurry of recent activity has meant that almost $1.5bn has been raised from initial public offerings (IPOs) by medtech companies so far in 2020. After a very quiet three months as equity markets plummeted due to the pandemic, it seems IPOs are back in favour in the medtech sector (see table).
In July, Renalytix AI plc raised $79m through an IPO on the Nasdaq Global Market. The company sold...







